脂质疾病的RNA干扰:这是未来吗?
Miguel Nassif1, Renata Turrini Jacob Fazoli1, Giuliano Generoso1,2
1Cardiology Center, Hospital Sirio Libanes.
Current opinion in lipidology
|February 28, 2026
概括
使用小干扰RNA (siRNA) 药物进行的RNA干扰 (RNAi) 疗法,为脂质疾病提供向基因沉默. 这些创新的治疗方法在治疗高胆固醇血症和降低心血管风险方面表现有前途.
科学领域:
- 生物化学和分子生物学
- 遗传学和基因组学 遗传学和基因组学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 脂质疾病,包括高胆固醇血症,是动脉样硬化心血管疾病的重要危险因素.
- 基因医学的进步为治疗干预开辟了新的途径.
- RNA干扰 (RNAi) 是一种具有治疗潜力的天然基因沉默机制.
研究的目的:
- 审查目前RNA干扰 (RNAi) 疗法的进展,特别是小干扰RNA (siRNA) 药物.
- 批判性地评估这些新疗法的临床定位.
- 探索RNAi在重塑脂质管理中的未来作用.
主要方法:
- 审查当前关于RNAi治疗脂质疾病的文献.
- 对已批准和正在研究的siRNA药物临床数据的分析.
- 评估RNAi疗法的作用机制,疗效,安全性和潜在应用.
主要成果:
- RNAi疗法在mRNA水平上提供了针对性和持久的脂质调节蛋白的抑制.
- 已批准的siRNA疗法Inclisiran可显著降低LDL-c水平,如果不经常服用.
- 研究性RNAi药物向脂蛋白 (a),阿波利波蛋白C-III和血管类蛋白3以解决残留心血管风险.
结论:
- 基于siRNA的疗法代表了脂质学中的颠覆性技术,有可能改变心血管疾病的预防和治疗.
- RNAi剂可能成为个性化脂质管理的基础,使长效和组合疗法成为可能.
- 目前正在进行的试验至关重要,以确认心血管益处和安全性,确定RNAi是否成为未来的护理标准.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
01:24Overview of Lipid Metabolism
6.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.2K
01:26Atherosclerosis III: Management
520
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
01:31Transducer Mechanism: Nuclear Receptors
3.8K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
3.8K
01:28Assembly of the Lipid Bilayer in the ER
4.3K
Biological membranes are more than just a barrier separating cell cytoplasm from the outside environment. They are highly dynamic and help maintain the integrity and physiological stability of the cells as well as membrane-bound organelles. Membranes also play vital roles in cell-to-cell and intracellular communication.
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
4.3K
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53